Oscar Health (NYSE:OSCR) Announces Earnings Results, Misses Estimates By $0.07 EPS

Oscar Health (NYSE:OSCR) issued its quarterly earnings data on Tuesday. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07), Zacks reports. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%.

Oscar Health Stock Performance

NYSE OSCR traded down $1.49 on Tuesday, hitting $15.27. 9,931,713 shares of the company traded hands, compared to its average volume of 3,324,902. The business’s 50 day moving average price is $15.22 and its 200-day moving average price is $16.85. Oscar Health has a 52-week low of $12.84 and a 52-week high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.77 billion, a price-to-earnings ratio of -254.37, a P/E/G ratio of 0.67 and a beta of 1.73.

Insider Activity at Oscar Health

In other Oscar Health news, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were bought at an average cost of $13.68 per share, with a total value of $5,756,803.92. Following the acquisition, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This trade represents a 8.36 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the sale, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at approximately $2,640,330.88. This trade represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. UBS Group initiated coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. Jefferies Financial Group assumed coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price objective on the stock. Finally, Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $21.56.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.